MIOSOTY DESUEZA: Open Payments
NPI 1831961010 · PATERSON, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,179 in 85 payments from 19 companies in 2025. Trend: 2023 $56 · 2024 $2,178 · 2025 $2,179
Food & beverage: $2,179
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 8 | $511 |
| AstraZeneca Pharmaceuticals LP | 5 | $314 |
| Novo Nordisk Inc | 15 | $270 |
| ABBVIE INC. | 18 | $254 |
| Amgen Inc. | 8 | $248 |
| Exact Sciences Corporation | 6 | $135 |
| Lilly USA, LLC | 6 | $105 |
| Corcept Therapeutics | 4 | $77 |
| GlaxoSmithKline, LLC. | 3 | $55 |
| Otsuka America Pharmaceutical, Inc. | 2 | $43 |
Products named: JARDIANCE, AIRSUPRA, Ozempic, Linzess, REPATHA, Cologuard Collection Kit, VRAYLAR, MOUNJARO.
Industry payments across NJ — which companies pay providers there.
